Signature Resources Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Buy
1,570
+28
+2% +$3.28K 0.08% 75
2026
Q1
$185K Sell
1,542
-12
-0.8% -$1.39K 0.09% 69
2025
Q4
$164K Buy
1,554
+35
+2% +$3.29K 0.08% 72
2025
Q3
$127K Sell
1,519
-413
-21% -$34K 0.07% 82
2025
Q2
$153K Buy
1,932
+459
+31% +$36.5K 0.09% 65
2025
Q1
$132K Hold
1,473
0.11% 63
2024
Q4
$147K Hold
1,473
0.13% 53
2024
Q3
$167K Sell
1,473
-48
-3% -$5.7K 0.15% 45
2024
Q2
$188K Hold
1,521
0.16% 48
2024
Q1
$166K Hold
1,521
0.16% 49
2023
Q4
$166K Buy
+1,521
New +$158K 0.15% 49

Other funds holding MRK

Signature Resources Capital Management's MRK Position: Q2 2026 in Review

Signature Resources Capital Management increased its Merck (MRK) stake by 1.8% in Q2 2026, buying an estimated $3.28K and bringing the position to 1,570 shares worth $202K. The position accounts for 0.08% of the portfolio, ranked #75.

Signature Resources Capital Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Signature Resources Capital Management held 1,570 shares of Merck worth $202K as of Q2 2026.
  • Signature Resources Capital Management bought 28 Merck shares in Q2 2026, an estimated $3.28K.
  • Merck made up 0.08% of Signature Resources Capital Management's portfolio in Q2 2026, its #75 holding.
  • Signature Resources Capital Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.